Rhythm

AtriCure and Baheal Group Establish Partnership and China Distribution Agreement

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib) and left atrial appendage management, today announced it has partnered with Baheal Pharmaceutical Group in China to distribute AtriCure’s surgical ablation devices. This new multi-year agreement establishes Baheal as the exclusive distributor for AtriCure, and replaces the […]

FDA Classifies HeartWare(TM) HVAD(TM) Systems Unexpected Power Source Switching as Class I Recall

DUBLIN – June 1, 2018 – The United States Food and Drug Administration (FDA) has classified Medtronic plc’s (NYSE: MDT) recent voluntary urgent field action related to the HeartWare(TM) HVAD(TM) System unexpected power source switching as a Class I recall. Class I recalls describe situations where there is reasonable risk of […]

Philips provides AEDs for New Cardiac Arrest Response System

AMSTERDAM and VAIL, Colo., June 1, 2018 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that it will be providing Philips HeartStart Onsite automated external defibrillators (AEDs) to Vail and Beaver Creek Mountains to create a cardiac arrest response system in collaboration with Starting Hearts and medic assist. To celebrate this, a launch event […]

A New Approach for Normalizing Cardiac Arrythmias

WASHINGTON, May 21, 2018 /PRNewswire/ — An article published in Experimental Biology and Medicine (Volume 243, Issue 8, May, 2018) identifies a new approach for treating cardiac arrythmias (http://journals.sagepub.com/doi/full/10.1177/1535370218769420). The study, led by Dr. Congxin Huang, in the Cardiovascular Research Institute at Wuhan University in China, reports that treatment with a β-receptor antagonist abolishes cardiac arrythmias in […]

Correvio Announces Enrollment of First Patient in Phase 3 Study Evaluating Brinavess® in China

VANCOUVER, May 17, 2018 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CRME / TSX: COM), formerly Cardiome Pharma Corp., today announced that its partner Eddingpharm has enrolled the first patient in a randomized, double-blind, placebo-controlled, Phase 3 clinical study evaluating Brinavess® versus placebo in patients with recent onset atrial fibrillation (AF).  Approximately 240 patients are expected […]

CareTaker Medical Completes $3.4M Investment to Expand Sales of Wireless “Beat-by-Beat” Continuous Blood Pressure and Vital Signs Monitor

CHARLOTTESVILLE, Va., May 16, 2018 /PRNewswire/ — CareTaker Medical, LLC, an innovator in Continuous Non-Invasive Blood Pressure and wireless Vital Signs monitoring today announced completion of a $3.4M investment round led by IrishAngels, KOFA Healthcare and Jaffray Woodriff (executed by his family office, Felton Group, LLC), with participation from both new and existing individual investors.  Proceeds will accelerate the […]

New Analysis Shows Medtronic Cardiac Resynchronization Therapy Feature Associated with Improved Patient Survival

DUBLIN – May 15, 2018 – Medtronic plc (NYSE: MDT) announced study results showing its exclusive AdaptivCRT(TM) algorithm is associated with improved patient survival. The data were recently presented at Heart Rhythm 2018, the Heart Rhythm Society’s 39th Annual Scientific Sessions in Boston. In a real-world, prospective registry of 1,835 patients, use […]

Impulse Dynamics Publishes FIX-HF-5C Clinical Trial Results

ORANGEBURG, New York, May 10, 2018 /PRNewswire/ —Impulse Dynamics(USA), Inc. announced results from its FIX-HF-5C randomized, Controlled Trial of Cardiac Contractility Modulation in Heart Failure. The study results were presented by Prof. William Abraham, MD, Professor of Internal Medicine and Director, Division of Cardiovascular Medicine, The Ohio State University Wexner […]

Murj Announces $8.5 Million Series B Financing for Cardiac Device Management Platform

SANTA CRUZ, Calif.–(BUSINESS WIRE)–Murj, Inc., a digital healthcare company dedicated to helping clinicians streamline and improve care for patients with implantable cardiac devices, today announced that the company has closed an $8.5 million Series B financing led by Longitude Capital, with participation from True Ventures and other existing investors. Murj […]